Your browser doesn't support javascript.
loading
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Moreau, Philippe; Attal, Michel; Hulin, Cyrille; Arnulf, Bertrand; Belhadj, Karim; Benboubker, Lotfi; Béné, Marie C; Broijl, Annemiek; Caillon, Hélène; Caillot, Denis; Corre, Jill; Delforge, Michel; Dejoie, Thomas; Doyen, Chantal; Facon, Thierry; Sonntag, Cécile; Fontan, Jean; Garderet, Laurent; Jie, Kon-Siong; Karlin, Lionel; Kuhnowski, Frédérique; Lambert, Jérôme; Leleu, Xavier; Lenain, Pascal; Macro, Margaret; Mathiot, Claire; Orsini-Piocelle, Frédérique; Perrot, Aurore; Stoppa, Anne-Marie; van de Donk, Niels Wcj; Wuilleme, Soraya; Zweegman, Sonja; Kolb, Brigitte; Touzeau, Cyrille; Roussel, Murielle; Tiab, Mourad; Marolleau, Jean-Pierre; Meuleman, Nathalie; Vekemans, Marie-Christiane; Westerman, Matthijs; Klein, Saskia K; Levin, Mark-David; Fermand, Jean Paul; Escoffre-Barbe, Martine; Eveillard, Jean-Richard; Garidi, Reda; Ahmadi, Tahamtan; Zhuang, Sen; Chiu, Christopher; Pei, Lixia.
Afiliación
  • Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France. Electronic address: philippe.moreau@chu-nantes.fr.
  • Attal M; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Hulin C; Department of Hematology, Hopital Haut Leveque, University Hospital Bordeaux, Bordeaux, France.
  • Arnulf B; Immuno-Hématologie, Hopital Saint Louis, Paris, France.
  • Belhadj K; Hematology, Hopital Henri Mondor, Creteil, France.
  • Benboubker L; Hôpital de Bretonneau, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
  • Béné MC; Hematology Biology, University Hospital Hôtel Dieu, Nantes, France.
  • Broijl A; Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands.
  • Caillon H; Biochemistry Laboratory, Hospital of Nantes, Nantes, France.
  • Caillot D; Hôpital Du Bocage, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Corre J; Unite de Genomique du Myelome, Institut universitaire du cancer de Toulouse Oncopole, Toulouse, France.
  • Delforge M; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Dejoie T; Biochemistry Laboratory, Hospital of Nantes, Nantes, France.
  • Doyen C; Centre Hospitalier Universitaire UCL Namur-site Godinne, Yvoir, Belgium.
  • Facon T; Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
  • Sonntag C; Hopital Hautepierre, Strasbourg, France.
  • Fontan J; Jean Minjoz Hôpital, Besancon, France.
  • Garderet L; Team Proliferation and Differentiation of Stem Cells, Centre de Recherche Saint-Antoine, Inserm, Sorbonne Université, Paris, France; Département d'Hématologie et de Thérapie Cellulaire, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Jie KS; Zuyderland Medisch Centrum, Sittard, Netherlands.
  • Karlin L; Service d'Hématologie Clinique, Centre Hospitalier Lyon-Sud, Lyon, France.
  • Kuhnowski F; Institut Curie Paris, Paris, France.
  • Lambert J; Biostatistical Department, Hôpital Saint Louis, Paris, France.
  • Leleu X; Hôpital la Milétrie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
  • Lenain P; Centre de Lutte Contre le Cancer-Centre Henri Becquerel, Rouen, France.
  • Macro M; Centre Hospitalier Universitaire de Caen, Caen, France.
  • Mathiot C; Institut Français de la Mode, Paris, France.
  • Orsini-Piocelle F; Centre Hospitalier Annecy Genevois, Pringy, France.
  • Perrot A; Hematology Department, Vandoeuvre Les Nancy, University Hospitals Nancy, France.
  • Stoppa AM; Institut Paoli Calmettes, Marseille, France.
  • van de Donk NW; Department of Hematology, University Medical Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Wuilleme S; Hematology Biology, University Hospital Hôtel Dieu, Nantes, France.
  • Zweegman S; Department of Hematology, University Medical Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Kolb B; Hôpital Robert Debré, Centre Hospitalier Universitaire de Reims, Reims, France.
  • Touzeau C; Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Roussel M; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
  • Tiab M; Centre Hospitalier Départemental Vendée, La Roche sur Yon, France.
  • Marolleau JP; Centre Hospitalier Universitaire Amiens Sud, Amiens, France.
  • Meuleman N; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Vekemans MC; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Westerman M; Northwest Clinics, Alkmaar, Netherlands.
  • Klein SK; Meander Medical Center, Amersfoort, Netherlands.
  • Levin MD; Albert Schweitzer Hospital, Dordrecht, Netherlands.
  • Fermand JP; Service d'Immuno-Hématologie, Département d'Immunologie Clinique, Inserm and Intergroupe Francophone du Myélome, Hôpital Saint-Louis, Paris, France.
  • Escoffre-Barbe M; Hôpital de Pontchaillou, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Eveillard JR; Hôpital A. Morvan, Centre Hospitalier Universitaire de Brest, Brest, France.
  • Garidi R; Hospital Center de Saint-Quentin, Saint Quentin, France.
  • Ahmadi T; Genmab US, Inc, Princeton, NJ, USA.
  • Zhuang S; Janssen Research & Development, Raritan, NJ, USA.
  • Chiu C; Janssen Research & Development, Spring House, PA, USA.
  • Pei L; Janssen Research & Development, Raritan, NJ, USA.
Lancet ; 394(10192): 29-38, 2019 07 06.
Article en En | MEDLINE | ID: mdl-31171419
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2019 Tipo del documento: Article